NEWS

Partner Releases

StartUp Health Launches ‘Longevity Moonshot’ and Invests in Human Longevity, Inc. to Change Face of Aging

New York, NY (PRWEB)April 13, 2016 — StartUp Health, a global organization leading the movement to transform health by building the world’s largest community of Healthcare Transformers, today announced the launch of StartUp Health’s Longevity Moonshot, a mission to extend and enhance healthy life by 50+ years and change the face of aging. Marked by StartUp Health’s recent investment in Human Longevity, Inc (HLI), the genomics-based, technology-driven company led by co-founder and CEO J. Craig Venter, PhD., HLI was selected to be the founding partner of the Longevity Moonshot and become the 140th company to join StartUp Health’s exclusive Academy for Healthcare Transformers.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Wins 2016 Bio-IT World Best Practice Award for the HLI Knowledgebase

Judges Honor Comprehensive Genome and Phenotype Database Curated with Proprietary Computational Tools by the Leading Experts in the Field

(SAN DIEGO, CA)—April 6, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, has won the 2016 Bio-IT World Best Practice Award for its HLI Knowledgebase™, a key tool in the company’s portfolio to transform how medicine is practiced.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Announces Promotions and Additions to Leadership Team

Kenneth Bloom, M.D. is President and Ashley Van Zeeland, Ph.D. is Chief Technology Officer, Insurance Industry Leader Tom Wamberg Hired to Head Insurance and Corporate Sales Group

(SAN DIEGO, CA)—April 6, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today several key promotions and additions to the company’s senior leadership team.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Completes $220 Million Series B Financing

(SAN DIEGO, CA)—April 4, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has completed an offering of Series B Preferred Stock, raising in excess of $220 million. HLI previously raised $80 million in its Series A offering which closed in Summer 2014.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. (HLI) Hires Key Oncology Leader, Kenneth J. Bloom, M.D., to Head Oncology and Immunotherapy Program

Stephen P. Schoenberger, Ph.D., to head cancer vaccine program and Ezra Cohen, M.D. is staff oncologist

(SAN DIEGO, CA)—February 3, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the appointment of several key people for its oncology genomics program. Kenneth J. Bloom, M.D. will join the company as the new head of oncology and immunotherapy; Stephen P. Schoenberger, Ph.D. will lead cancer vaccine efforts and Ezra Cohen, M.D., who is also Associate Director and Professor of Medicine, Moores Cancer Center, University of California, San Diego, will be a staff oncologist.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing with Strategic Acquisition of Stem Cell Banking from Celgene Cellular Therapeutics

HLI to Offer Newborn Genome Sequencing Product in Combination with Stem Cell Banking

(SAN DIEGO, CA)—January 28, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has agreed to purchase LifebankUSA, a leader in placental and cord blood banking, along with its proprietary and high-yield method for extracting placental stem cells and related therapeutic programs, and the biomaterials program which includes the marketed product Biovance®, a cell matrix critical to wound healing applications.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. (HLI) to Offer Oncology Products Including Comprehensive Whole Germline, Tumor Genome and Whole Cancer Exome Products

(SAN DIEGO, CA)—January 12, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today its oncology genomics program, including the development of comprehensive whole germline and tumor genome analysis, as well as tumor and germline exome analysis products.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. (HLI) Acquires Cypher Genomics, Inc.

Cypher CEO, Ashley Van Zeeland, Ph.D. to become head of HLI’s Pediatric Business

(SAN DIEGO, CA)—November 30, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI’s Pediatric Business. Financial details of the deal were not disclosed.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Hires Sally A. Howard as Head of Regulatory Affairs and Policy

(SAN DIEGO, CA) November 4, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Sally Howard, J.D., has been hired as Head of Regulatory Affairs and Policy. Howard, who has more than two decades of health policy and regulatory expertise, will lead all efforts related to federal and state regulatory oversight for HLI.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Venter Institute Scientists Publish Paper Demonstrating Inconsistency in Microbiome Studies due to Variable Approaches to DNA Sequencing and Data Analysis

Comparison of four common library prep methods found significant differences in types of microbes uncovered and showed biases in error and duplication rates

(SAN DIEGO, CA)—October 26, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that its researchers along with those from the J. Craig Venter Institute and the University of California, San Diego, have published a paper in the journal, Proceedings of the National Academy of Sciences (PNAS), outlining the confusing and conflicting microbiome results generated by a variety of next generation sequencing technology. They also outline recommendations for new research community standards in the microbiome research field given these differences. The paper is being published this week in the early online edition of PNAS.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets